Chemotherapy-induced Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting [Phase 2]
A Phase 2 clinical trial evaluated whether yoga reduces chemotherapy-induced nausea and vomiting in patients with breast cancer, malignant n…
-
CLINICAL_TRIALS trial_result · 2013-05-24Clinical Trial Update: Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation [EARLY_Phase 1]
This early-phase study reports preliminary data on the efficacy and safety of combining aprepitant with ondansetron and dexamethasone to pre…
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting [Phase 4]
Phase 4 trial update reports on the efficacy and safety of palonosetron hydrochloride for preventing chemotherapy-induced nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Treatment of Chemotherapy-induced Nausea and Vomiting [Phase 2]
A Phase 2 trial evaluating treatment for chemotherapy-induced nausea and vomiting has completed. The provided snippet does not include trial…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting [Phase 3]
Phase 3 trial evaluating stimulation of an auricular acupuncture point for chemotherapy-induced nausea and vomiting in cancer patients has c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Re-examination Study of EMEND (Aprepitant) (MK-0869-184)
A re-examination study of EMEND (aprepitant) completed, with results posted in 2012 evaluating prevention of chemotherapy-induced nausea and…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Phase II Proof-of-concept Study of APD421 [Phase 2]
A Phase II proof-of-concept study of APD421 for chemotherapy-induced nausea and vomiting has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting [Phase 3]
A Phase 3 trial evaluating intravenous and oral casopitant for prevention of chemotherapy-induced nausea and vomiting has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy) [Phase 4]
Phase 4 study evaluating the efficacy and safety of the Sancuso transdermal granisetron patch for preventing chemotherapy-induced nausea and…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy [Phase 3]
Phase 3 trial assessing whether continuing dexamethasone after emetogenic chemotherapy improves quality of life in cancer patients; the stud…
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting [Phase 2]
Phase 2 clinical trial evaluating carbamazepine for prevention of chemotherapy-induced nausea and vomiting, assessing its efficacy and safet…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition [Phase 1]
This update reports the completion of a Phase 1 bioequivalence study of Ondansetron 8 mg tablets under fasting conditions.
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183) [Phase 1]
This Phase 1 clinical trial evaluating time-on-target PET imaging for aprepitant and fosaprepitant in chemotherapy-induced nausea and vomiti…
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED) [Phase 3]
Phase 3 trial update of aprepitant (MK0869) for prevention of chemotherapy-induced nausea and vomiting in cisplatin-treated patients; trial …
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX [Phase 2]
Phase II trial evaluating the combination of aprepitant and palonosetron for prevention of chemotherapy-induced nausea and vomiting in color…
-
CLINICAL_TRIALS trial_result · 2011-07-07Clinical Trial Update: Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy [Phase 3]
Phase 3 clinical trial comparing palonosetron with granisetron for prevention of chemotherapy-induced nausea and vomiting in patients receiv…
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting [Phase 2]
Phase 2 study evaluating the efficacy, tolerability, and safety of intranasal granisetron for preventing chemotherapy-induced nausea and vom…
-
CLINICAL_TRIALS trial_result · 2011-02-03Clinical Trial Update: Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting [Phase 2]
A Phase 2 randomized trial compared palonosetron to ondansetron for the prevention of chemotherapy-induced nausea and vomiting in patients w…
-
CLINICAL_TRIALS trial_result · 2010-12-02Clinical Trial Update: A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting [Phase 4]
Phase IV trial of Cesamet (nabilone) plus standard antiemetic therapy for chemotherapy-induced nausea and vomiting has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-09-17Clinical Trial Update: Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting [Phase 2]
Phase 2 clinical trial results for Palonosetron in preventing chemotherapy-induced nausea and vomiting have been completed, reporting safety…
-
CLINICAL_TRIALS trial_result · 2010-08-26Clinical Trial Update: A Bioequivalence Study of 3 Formulations of Ondansetron in Healthy Adults (0869-095)(COMPLETED) [Phase 1]
Phase 1 bioequivalence study in healthy adults comparing three formulations of ondansetron for prevention of chemotherapy-induced nausea and…
-
CLINICAL_TRIALS trial_result · 2010-06-30Clinical Trial Update: A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165) [Phase 1]
This Phase 1 study assessed bioequivalence between aprepitant and fosaprepitant and evaluated the effect of food on aprepitant bioavailabili…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106) [Phase 1]
A Phase 1 bioequivalence study comparing two ondansetron formulations in healthy adults, with results posted.
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy [Phase 2]
A Phase 2 clinical trial completed evaluating prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving highly eme…
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017) [Phase 3]
A Phase 3 study evaluating a single-dose fosaprepitant (MK0517) regimen for preventing chemotherapy-induced nausea and vomiting has been com…